Black Diamond Therapeutics I

Penny Stocks Biotech Stocks Healthcare Stocks

$1.95

+0.03 (+1.56%)

As of Aug 15, 2:15 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +1,742.1% upside

Low Target $30.62

Average Target $35.92

High Target $44.24

Current Price $1.95

Current
$1.95

Target
$35.92

$30.62 $35.92 avg $44.24

Scenario Analysis

Bear Case

$30.62

1,470.3%

Low target

Base Case

$35.92

+1,742.1%

Avg target

Bull Case

$44.24

+2,168.7%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$4.94

-60.5% from high

52-Week Low

$1.60

+21.9% from low

Target vs 52W High

$35.92

+627.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%